Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES.
EQS-News: SHOP APOTHEKE EUROPE: STRONG ORGANIC GROWTH CONTINUES.
Novocure: LUNAR-Studie erreicht primären Endpunkt für Gesamtüberleben bei nicht kleinzelligem Lungenkrebs
Novocure: LUNAR-Studie erreicht primären Endpunkt für Gesamtüberleben bei nicht kleinzelligem Lungenkrebs


Wie Novocure (NASDAQ: NVCR) heute mitteilte, hat die LUNAR-Studie ihren primären Endpunkt erreicht und eine statistisch signifikante und klinisch bedeutsame Verbesserung des Gesamtüberlebens im

SolarEdge and Sunnova Expand Partnership to Include SolarEdge Home Battery in Sunnova’s Energy as a Service Portfolio: https://mms.businesswire.com/media/20230109005689/en/1681665/5/Solaredge_Home_Battery_photo.jpg
SolarEdge and Sunnova Expand Partnership to Include SolarEdge Home Battery in Sunnova’s Energy as a Service Portfolio


SolarEdge Technologies, Inc. (“SolarEdge”) (NASDAQ: SEDG), a global leader in smart energy technology, and Sunnova Energy International, Inc. ("Sunnova") (NYSE: NOVA), a leading U.S. Energy as a

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: Nagarro SE: Guidance FY 2023: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE: Guidance FY 2023
EQS-News: Nagarro SE: Guidance FY 2023
EQS-News: Nagarro SE: Guidance FY 2023: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro SE: Guidance FY 2023
EQS-News: Nagarro SE: Guidance FY 2023
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
EQS-News: MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
EQS-Adhoc: Rheinmetall AG: A record year for Rheinmetall AG: based on preliminary figures, double-digit percentage sales growth with significant increase in operating margin: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23734/Rheinmetall_AG_Logo.svg.png
EQS-Adhoc: Rheinmetall AG: A record year for Rheinmetall AG: based on preliminary figures, double-digit percentage sales growth with significant increase in operating margin
EQS-Adhoc: Rheinmetall AG: A record year for Rheinmetall AG: based on preliminary figures, double-digit percentage sales growth with significant increase in operating margin
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Semtech Corporation and Sierra Wireless Announce Termination of the Waiting Period Under the HSR Act: https://mms.businesswire.com/media/20230105005923/en/1678528/5/USE_THIS_LOGO_FOR_PRESS_RELEASES.jpg
Semtech Corporation and Sierra Wireless Announce Termination of the Waiting Period Under the HSR Act


Semtech Corporation (Nasdaq: SMTC) (“Semtech”) and Sierra Wireless, Inc. (Nasdaq: SWIR) (TSX: SW) (“Sierra”) today announced the termination of the applicable waiting period under the

TUI AG: NOTICE OF 2023 ANNUAL GENERAL MEETING : https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: NOTICE OF 2023 ANNUAL GENERAL MEETING
TUI AG: NOTICE OF 2023 ANNUAL GENERAL MEETING
Semtech’s LoRa® Devices and the LoRaWAN® Standard Optimize Smart Metering with Sindcon: https://mms.businesswire.com/media/20230105005376/en/1677720/5/lora-sindcon-pr-press.jpg
Semtech’s LoRa® Devices and the LoRaWAN® Standard Optimize Smart Metering with Sindcon


Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that Sindcon (Singapore) IoT Technology

EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-News: MorphoSys Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2022 Monjuvi U.S. Net Product Sales, Provides 2023 Financial Guidance and Reduces Financial Liability
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Acadia Healthcare Names Laura Groschen Company’s New Chief Information Officer: https://mms.businesswire.com/media/20230103005504/en/1675242/5/Laura_Groschen_photolarger.jpg
Acadia Healthcare Names Laura Groschen Company’s New Chief Information Officer


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Laura Groschen has joined Acadia as the Company’s new Chief Information Officer (CIO). In this role, she will shape and advance

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group
EQS-News: CANCOM SE: Endpoint management specialist NWC Services becomes part of the CANCOM Group
EQS-News: GEA successfully completes share buyback program: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23714/375px-GEA_Group_2010_logo.svg.png
EQS-News: GEA successfully completes share buyback program
EQS-News: GEA successfully completes share buyback program
EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched
EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched